MEZZAN HOLDING LOGO.jpg
Mezzan Holding Reports Full-Year 2024 Results
March 20, 2025 13:07 ET | Mezzan Holding
KUWAIT CITY, March 20, 2025 (GLOBE NEWSWIRE) -- Mezzan Holding KSC (Bloomberg: MEZZAN.KK, Reuters: MEZZ.KW), one of the largest manufacturers and distributors of food, beverage, FMCG, and...
imr_introspective_market_research_logo_original-ezgif.com-webp-to-jpg-converter.jpg
Clinical Towel and Wiping Products Market to Reach USD 9.2 Billion by 2032 | Industry Analysis and Forecast 2032
March 19, 2025 08:22 ET | Introspective Market Research
Dublin, March 19, 2025 (GLOBE NEWSWIRE) -- Introspective Market Research is pleased to announce the publication of its latest report, Clinical Towel and Wiping Products Market. This in-depth...
Picture2.png
Scienture Holdings Announces Draw on ELOC, Temporarily Suspends Further Draws Until Reaching $10/Share or 30 Trading Days
March 19, 2025 08:05 ET | Scienture Holdings, Inc.
TAMPA, FL, March 19, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced...
Hengdian Group 1
Hengdian Group looks back on 50 years of growth and giving back
March 18, 2025 10:43 ET | Hengdian Group
This year, Hengdian Group celebrates its 50th anniversary, marking five decades of growth and steadfast commitment to giving back.
Lifecore-Corporate_Logo_2C.png
Humanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation Syndrome
March 17, 2025 07:00 ET | Lifecore Biomedical, Inc.
Humanetics’ Novel Radioprotective Agent Being Developed with Funding from Department of Defense as Radiation Medical Countermeasure (MCM) Lifecore to Carry Out Tech Transfer and Analytical Method...
Capture
Celex Oncology Announce Novel Mechanism in Cancer Care and Attendance at Bio-Europe Spring 2025
March 17, 2025 03:00 ET | Celex Oncology Innovations Limited
Celex Oncology, a UK biotechnology on the brink of launching the fourth revolution in cancer care, today announced their investigative model and treatment.
Dr. Otis Johnson
YPrime Earns Prestigious EcoVadis Rating, Strengthening Commitment to Sustainable and Responsible Clinical Research
March 12, 2025 08:00 ET | Y-Prime, LLC
YPrime earns prestigious EcoVadis rating, reinforcing commitment to sustainable clinical research.
Woodstock Sterile Solutions
Woodstock Sterile Solutions Invests $8 million in New Automated, High-Speed, State-of-the-Art, Bottle Packaging Line
March 11, 2025 09:00 ET | Woodstock Sterile Solutions
Woodstrock Sterile Solutions is investing $8 million in a new automated, high-speed bottle packaging line at its facility in Woodstock, Illinois.
Kaerus Logo
Kaerus Bioscience Successfully Completes Phase 1 Trial and Demonstrates Proof of Mechanism with its Novel BK Channel Modulator KER-0193 being developed for Fragile X Syndrome
March 11, 2025 08:33 ET | Kaerus Bioscience
Kaerus announces its novel BK channel modulator KER-0193 is safe and well tolerated in Phase 1, also demonstrating proof of mechanism with EEG biomarker.
Kaerus Logo
Kaerus Bioscience Successfully Completes Phase 1 Trial and Demonstrates Proof of Mechanism with its Novel BK Channel Modulator KER-0193 being developed for Fragile X Syndrome
March 11, 2025 06:00 ET | Kaerus Bioscience
Kaerus announces its novel BK channel modulator KER-0193 is safe and well tolerated in Phase 1, also demonstrating proof of mechanism with EEG biomarker.